Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- System usability
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
The purpose of this study is to determine the extent to which an online pathway to depression treatment (iPath*D) is acceptable and usable to patients receiving cancer treatment who report symptoms of depression.
Detailed Description
The investigators will determine the extent to which an online pathway to depression treatment (iPath\*D) is acceptable and usable to patients receiving cancer treatment who report symptoms of depression. iPath\*D will be designed to increase screening, mental health literacy, and treatment access. Patients will access their iPath\*D account online to review their PHQ-9 score and its interpretation, followed by an interactive depression decision aid comparing information on a range of online and in-person treatment options. Upon review of the decision aid, participants will be able to directly connect to a treatment path via embedded hyperlinks in the decision aid. The investigators will determine the usability, acceptability, and feasibility of iPath\*D. The investigators will explore the hypothesis that iPath\*D will be highly usable, acceptable to patients, feasible to implement, and will result in improved mental health literacy, and greater treatment access. The tool for the study was developed during a preliminary portion (Aim 1) of the project, under D-H IRB number STUDY02001240 . This approach uses an open-label, single arm pilot, with adult patients receiving treatment for cancer in a rural cancer clinic, St Johnsbury, VT (Dartmouth Cancer Center North) (n=30) with moderate-severe depression, Aim 2 of the project.
Investigators
Paul J. Barr
Associate Professor
Trustees of Dartmouth College
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
System usability
Time Frame: 2 weeks
System Usability Scale (10 items; mean ≥68/100),
Acceptability of intervention
Time Frame: 2 weeks
Acceptability of Intervention Measure (4 items), mean ≥4/5
Feasibility of intervention
Time Frame: 2 weeks
Feasibility of Intervention Measure (4 items), mean ≥4/5
Change in Mental Health Literacy (MHL)
Time Frame: Baseline, 2 weeks
A modified 10-item version for the validated multiple choice questionnaire (MCQ) for depression assesses treatment knowledge, understanding \& beliefs. Higher scores indicate higher MHL.
Change in number of patients selecting a treatment path to access
Time Frame: 2 weeks, 4 weeks, 6 weeks
Click on link to access online treatment service \| indicate in self-report survey accessing local resources
Secondary Outcomes
- Change in treatment initiation (exploratory outcome)(2 weeks, 4 weeks, 6 weeks)
- Decisional regret (exploratory outcome)(6 weeks)
- Change in PHQ-9 completion (exploratory outcome)(Baseline, 2 weeks, 4 weeks, 6 weeks)
- Change in treatment adherence (exploratory outcome)(2 weeks, 4 weeks, 6 weeks)
- Change in quality of life (exploratory outcome)(Baseline, 6 weeks)
- Change in PHQ-9 score (exploratory outcome)(Baseline, 2 weeks, 4 weeks, 6 weeks)